Home > Resources > Videos > Introduction & Welcome: Fake Medicines - Imminent Risks to Global Health to Global Health

Introduction & Welcome: Fake Medicines - Imminent Risks to Global Health to Global Health

Introduction & Welcome: Fake Medicines - Imminent Risks to Global Health to Global Health.David Taylor, Professor of Pharmaceutical and Public Health Policy, UCL School of Pharmacy.

Spotlight

Pharmaceutical Manufacturers Association of Turkey / İlaç Endüstrisi İşverenler Sendikası (İEİS)

IEIS was established in 1964 to improve and bolster business conditions of its members and to contribute to the development of healthcare policies in Turkey. Pharmaceutical production is the primary activity of our local and multinational members. We cater to a diverse group of companies with different business interests stretching from originator products to branded generics, manufacturing and importing of pharmaceuticals and active ingredients, marketing of biological products (blood products, vaccines, etc.) as well as contract manufacturers.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

Pharmaceutical Manufacturers Association of Turkey / İlaç Endüstrisi İşverenler Sendikası (İEİS)

IEIS was established in 1964 to improve and bolster business conditions of its members and to contribute to the development of healthcare policies in Turkey. Pharmaceutical production is the primary activity of our local and multinational members. We cater to a diverse group of companies with different business interests stretching from originator products to branded generics, manufacturing and importing of pharmaceuticals and active ingredients, marketing of biological products (blood products, vaccines, etc.) as well as contract manufacturers.

Events